| 000 | 01179 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250511200606.0 | ||
| 264 | 0 | _c19911105 | |
| 008 | 199111s 0 0 eng d | ||
| 022 | _a0140-6736 | ||
| 024 | 7 |
_a10.1016/0140-6736(91)91804-4 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBonhomme, M G | |
| 245 | 0 | 0 |
_aSafety of depot medroxyprogesterone acetate. _h[electronic resource] |
| 260 |
_bLancet (London, England) _cOct 1991 |
||
| 300 |
_a942 p. _bdigital |
||
| 500 | _aPublication Type: Comment; Letter | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aBreast Neoplasms _xchemically induced |
| 650 | 0 | 4 |
_aContraceptive Agents, Female _xadverse effects |
| 650 | 0 | 4 | _aDelayed-Action Preparations |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLife Expectancy |
| 650 | 0 | 4 |
_aMedroxyprogesterone _xadverse effects |
| 650 | 0 | 4 | _aMedroxyprogesterone Acetate |
| 650 | 0 | 4 | _aMiddle Aged |
| 700 | 1 | _aPotts, D M | |
| 700 | 1 | _aFortney, J A | |
| 700 | 1 | _aAllen, M Y | |
| 773 | 0 |
_tLancet (London, England) _gvol. 338 _gno. 8772 _gp. 942 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0140-6736(91)91804-4 _zAvailable from publisher's website |
| 999 |
_c1687695 _d1687695 |
||